Related Experiment Video
Updated: Feb 8, 2026

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression
1School of Life Sciences, Chongqing University, Chongqing 401331, PR China.
Abstract:
The tyrosine phosphatases family member PTEN is a tumor suppressor which is widely expressed throughout the body and is involved in a variety of biological functions. PTEN is known to be frequently mutated or downregulated in human cancers. However, the underlying molecular mechanism remains largely unknown. Here, using a proteomic approach, we identified the E3 ubiquitin ligase HRD1, which was previously reported to be involved in endoplasmic reticulum associated degradation (ERAD), as one of the PTEN-interacting proteins. We also found that HRD1 promoted PTEN degradation by positively regulating its ubiquitination. In addition, suppression of HRD1 expression resulted in the inhibition of the growth, migration and invasion of hepatocellular carcinoma in vitro and in vivo. Finally, we detected a negative correlation between HRD1 and PTEN expression in human hepatocellular carcinoma. From these results we propose a novel molecular mechanism of HRD1 to promote hepatocellular tumorigenesis via PTEN inactivation. We conclude that targeting HRD1 may represent a new therapeutic strategy for PTEN-loss hepatocellular carcinoma.
Insights
The E3 ubiquitin ligase HRD1 targets the tumor suppressor PTEN for degradation, promoting hepatocellular carcinoma growth. Inhibiting HRD1 may offer a new therapeutic strategy for PTEN-loss cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- PTEN is a crucial tumor suppressor frequently altered in human cancers.
- The molecular mechanisms driving PTEN downregulation in cancer are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying PTEN dysregulation in cancer.
- To identify novel therapeutic targets for hepatocellular carcinoma.
Main Methods:
- Proteomic analysis to identify PTEN-interacting proteins.
- Investigation of HRD1's role in PTEN ubiquitination and degradation.
- In vitro and in vivo studies assessing the impact of HRD1 suppression on hepatocellular carcinoma.
- Correlation analysis of HRD1 and PTEN expression in human hepatocellular carcinoma samples.
Main Results:
- HRD1, an E3 ubiquitin ligase, interacts with PTEN.
- HRD1 promotes PTEN degradation by increasing its ubiquitination.
- Suppression of HRD1 inhibits hepatocellular carcinoma cell growth, migration, and invasion.
- A negative correlation exists between HRD1 and PTEN expression in hepatocellular carcinoma.
Conclusions:
- HRD1 promotes hepatocellular tumorigenesis by inactivating PTEN.
- Targeting HRD1 represents a potential therapeutic strategy for PTEN-loss hepatocellular carcinoma.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Cells Coordinate Growth and Proliferation
The Eukaryotic Promoter Region
Abnormal Proliferation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

